Barrow, Hanley, Mewhinney & Strauss’s MaxLinear MXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.4K Sell
89
-129
-59% -$9.13K ﹤0.01% 233
2026
Q1
$3.79K Buy
+218
New +$3.92K ﹤0.01% 289
2021
Q4
– Sell
-2,302
Closed -$113K – 354
2021
Q3
$113K Sell
2,302
-788
-26% -$38.1K ﹤0.01% 204
2021
Q2
$131K Buy
+3,090
New +$115K ﹤0.01% 176

Other funds holding MXL

Barrow, Hanley, Mewhinney & Strauss's MXL Position: Q2 2026 in Review

Barrow, Hanley, Mewhinney & Strauss reduced its MaxLinear (MXL) stake by 59% in Q2 2026, selling an estimated $9.13K and leaving 89 shares worth $11.4K. The position accounts for ﹤0.01% of the portfolio, ranked #233.

Barrow, Hanley, Mewhinney & Strauss first reported a position in MXL in Q2 2021 and has held it in 4 quarters since. The position peaked at $131K in Q2 2021. 435 funds tracked by Wall St. Rank hold MXL as of Q2 2026.

  • Barrow, Hanley, Mewhinney & Strauss held 89 shares of MaxLinear worth $11.4K as of Q2 2026.
  • Barrow, Hanley, Mewhinney & Strauss sold 129 MaxLinear shares in Q2 2026, an estimated $9.13K.
  • MaxLinear made up ﹤0.01% of Barrow, Hanley, Mewhinney & Strauss's portfolio in Q2 2026, its #233 holding.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in MaxLinear in Q2 2021 and has held it in 4 quarters since.
  • Barrow, Hanley, Mewhinney & Strauss's MaxLinear position peaked at $131K in Q2 2021.
  • 435 funds tracked by Wall St. Rank held MaxLinear as of Q2 2026.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q2 2026, filed 12 Aug 2026.